Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.

Last week during the NASCAR Clash at Bowman Gray, Ty Gibbs gave a hit to Justin Haley under caution that became controversial ...

Dave Bartosiak's technical analysis approach adds depth to our understanding Palantir stock chart. By paying attention to moving averages, support and resistance levels, chart patterns, technical ...

Construction materials supplier CRH cleared a buy point Thursday after announcing plans to unload its stake in SigmaRoc.

Ninja’s latest blender system combines smoothie-making prowess with serious muscle for thick bowls and butters. This versatile 1200-watt powerhouse comes with both a traditional smoothie cup and a ...

Ripple (XRP) gathers steam for its next big leap, while Shiba Inu (SHIB) is a memecoin to watch; DTX Exchange (DTX), a new ...

Source: John Newell 02/04/2025 John Newell of John Newell & Associates takes a look at the early-stage exploration market, which he believes is poised for a breakout.

Under Wilson Combat's ownership, New Ultralight Arms has introduced a mini action: the NULA 20S. Here's how it performed for ...

Have you ever marveled at the delicate beauty of a Japanese glass tea set? As you explore the world of tea culture, you can ...

On stocks to buy on Thursday, Osho Krishan of Angel One recommended two stocks - Ashok Leyland Ltd, and NBCC (India) Ltd.

Still just 19 years old, Soler’s arrival keeps the average age of Iraola’s 17 permanent signings at Bournemouth under 21.

New month comes fresh opportunities, challenges, and chances of growth. Let's take a look at what the cards reveal for each ...